What are the validations that larger molecular profiling panels -- using NGS to interrogate several hundred genes and provide comprehensive genomic profiles -- are superior to targeted or hot spot panels?

What are the validations that larger molecular profiling panels -- using NGS to interrogate several hundred genes and provide comprehensive genomic profiles -- are superior to targeted or hot spot panels?

What are the validations demonstrating that larger molecular profiling panels — those that use NGS to interrogate several hundred genes and provide comprehensive genomic profiles— are superior to targeted or hot spot panels?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Razelle Kurzrock, MD

Razelle Kurzrock, MD

Chief, Division of Hematology and Oncology
UCSD School of Medicine
Senior Deputy Director, Clinical Science
Director, Center for Personalized Cancer Therapy
Director, Clinical Trials Office
UCSD Moores Cancer Center
San Diego, California